Update on COVID-19 Therapeutics (March 2022 Edition) - D.Kuritzkes, MD

COVID-19 Clinical Forum 2022

Operationalisation of Model for Dynamics of COVID-19 in Kenya - Trajectory of Omicron Wave in Kenya - Shem Sam

International Workshop on COVID-19 Vaccines 2022 - June Edition

Abstract #8 - Vascular Inflammation in Neuropsychiatric Post-Acute Sequelae of COVID-19 - Lindsay McAlpine.pdf

Demystifying Long COVID International Conference 2023

VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD

International Workshop on HBV Cure 2021

Assessing the Conditional Dependencies of Post-COVID Symptoms using Network Analysis | Elizabeth Upton

Demystifying Long COVID North American Conference 2024

Molecular PET Imaging of Long COVID_Eric Guedj, MD, Dipl.-Ing, PhD

Demystifying Long COVID International Conference 2024

Shelter From the Storm? Reassessing the Role of Tocilizumab in COVID-19 Pneumonia - Jonathan Parr, MD, MPH

COVID-19 Online Educational Program 2020

Results from two phase-3 double-blind, randomized, controlled trials, PROTECT and CONSTANT, evaluating immunogenicity and safety of the 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared to the single-antigen vaccine, Engerix ® in adults

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Plenary Lecture: Opportunities and Challenges for a Broadly Protective Influenza Vaccine | Gary Nabel, MD

RespiDART 2018

Decreased Hepatitis B Vaccine Efficacy in Obese Individuals and Approaches to Previously Immunized Non-Responders

Conference on Liver Disease in Africa (COLDA) 2019